Chambers Rebecca
Visual SEC Form 4 history across 2 companies, 8 transactions and 4 filings.
Open-market buy performance
90-day forward return on this insider's open-market purchases
We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.
Monthly open-market activity
Reported purchase and sale transaction counts
Net value flow
Buys minus sells
Transaction texture
Ownership and ticket size
Filing-only signals
Deterministic matches in this insider's history
Latest Form 4 facts
Quick context from source filings
No open-market insider purchase is available.
Associated companies
Visual map of known reporting history
| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| VCYT | Chambers Rebecca | CFO | sale10b5-1 | 1.17k | -$5.13M | S | 0.0% | 09/04 | 09/04 | |
| VCYT | Chambers Rebecca | CFO | sale10b5-1 | 2.47k | -$10.6M | S | 0.0% | 09/04 | 09/04 | |
| VCYT | Chambers Rebecca | CFO | withholding10b5-1 | 3.60k | -$16.1M | F | 0.0% | 09/04 | 09/02 | |
| VCYT | Chambers Rebecca | CFO | withholding | 11.0k | -$38.4M | F | — | 03/03/2025 | 03/02/2025 | |
| VCYT | Chambers Rebecca | CFO | withholding | 11.9k | -$40.3M | F | — | 03/03/2025 | 02/27/2025 | |
| VCYT | Chambers Rebecca | CFO | grant | 23.1k | $0 | A | — | 03/03/2025 | 02/27/2025 | |
| NARI | Chambers Rebecca | DIR | U | 9.68k | — | U | — | 02/20/2025 | 02/19/2025 | |
| VCYT | Chambers Rebecca | CFO | sale10b5-1 | 527 | -$2.31M | S | — | 02/05/2025 | 02/03/2025 |
Chambers Rebecca Insider Activity FAQ
SEC Form 4 context
Who is Chambers Rebecca?
Chambers Rebecca is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001823563.
Which companies has Chambers Rebecca reported transactions for?
VERACYTE, INC., Inari Medical, Inc.
When was Chambers Rebecca's latest insider buy?
No open-market insider purchase is available for this period.
When was Chambers Rebecca's latest insider sale?
sale at VERACYTE, INC. on Sep 04, 2026 valued at $51,364.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.